FBIO today
$1.88-$0.11 (-5.53%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $2.17
Key levels
Resistance$2.18
Resistance$2.07
Support$1.86
Support$1.75
Latest news & SEC filings
EarningsFortress Biotech Posts Q3 2026 Results, Notes Corporate Updates
EarningsFortress Biotech posts wider quarterly loss as revenue falls short
SEC FilingFortress Biotech, Inc. filed a report on a major company event (Form 8-K)
All FBIO news →About Fortress Biotech
Fortress Biotech is a biopharmaceutical company that acquires and develops drug assets, working with universities, research institutes, and pharmaceutical firms. It operates through subsidiaries and partner companies, including Journey Medical, Mustang Bio, Avenue Therapeutics, Cyprium, Helocyte, and Urica. Its portfolio spans marketed dermatology products and development-stage candidates in oncology, rare diseases, and immunology. The company operates primarily in the United States.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
Fortress Biotech, Inc. (FBIO)
What Is the Price Target for FBIO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is FBIO a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.7% YoY with DECLINING trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for FBIO.
Start Free Trial →Is FBIO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG
Fair Value
$19.41
22
Moat Score
NONE
4/9
Piotroski Score
-5.7
Altman Z-Score
What Is Smart Money Doing with FBIO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Jin David | officer | Buy | 1,190 | $2K | Oct 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →FBIO Growth Story
Revenue YoY
9.7%
3yr Revenue CAGR
-5.8%
EPS Growth YoY
97.4%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Dark Pool Trades for FBIO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for FBIO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:54:47 | $1.91 | 5,000 | $$10K | SELL |
| 20:47:38 | $1.92 | 2,350 | $$5K | MIDPOINT |
| 20:43:39 | $1.92 | 1,000 | $$2K | MIDPOINT |
| 20:18:56 | $1.92 | 2,000 | $$4K | SELL |
| 20:09:16 | $1.93 | 1,000 | $$2K | SELL |
5 dark pool trades shown · $$22K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Fortress Biotech, Inc. (FBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →FBIO — frequently asked questions
What is FBIO stock price today?
Fortress Biotech, Inc. (FBIO) is at $1.88, down 5.53% (-$0.11) at the Nov 13, 2026 close.
Why is FBIO stock moving today?
Latest FBIO news — Nov 13, 2026: Fortress Biotech Posts Q3 2026 Results, Notes Corporate Updates · Nov 13, 2026: Fortress Biotech posts wider quarterly loss as revenue falls short
What do analysts rate FBIO?
Analyst ratings for FBIO: 2 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did FBIO beat earnings?
FBIO last reported on Aug 13, 2026: EPS -$0.08 vs -$0.20 expected — a beat of 60.0%.
What is FBIO's P/E ratio?
FBIO trades at a P/E of 0.7 vs a Healthcare average of 17.4.
Does FBIO pay a dividend?
Yes. FBIO's dividend yield is 11.16%.
How much debt does FBIO have?
Fortress Biotech, Inc. reported $35M of debt and $197M of cash (Jun 30, 2026).
What are FBIO support and resistance levels?
Support: $1.86, $1.75, $1.60. Resistance: $2.07, $2.18, $2.41.
What are insiders doing with FBIO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on FBIO?
Nov 13, 2026: Fortress Biotech Posts Q3 2026 Results, Notes Corporate Updates · Nov 13, 2026: Fortress Biotech posts wider quarterly loss as revenue falls short · Nov 13, 2026: Fortress Biotech, Inc. filed a report on a major company event (Form 8-K)